Selected Grants
External Quality Assurance Program Oversight Laboratory (EQAPOL)
ResearchInvestigator · Awarded by National Institutes of Health · 2024 - 2031Neutralizing Antibody Assessment to Support bnAb Production
ResearchDirector · Awarded by Advanced Bioscience Laboratories, Inc. · 2024 - 2028HIV Vaccine Trials Network Laboratory Center
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2027ABL PGDM14 BIJ93.LS Stability Testing Program (Opt 1)
ResearchDirector · Awarded by Advanced Bioscience Laboratories, Inc. · 2024 - 2027Moderna mRNA 1273 P403-M (SARS Cov 2) Vaccine Trial Neutralizing Antibody Assessment and SARS-CoV-2 Variant Characterization and Validation
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2024 - 2026CISA 2023-03 Task 4 Lead - COVID immunogenicity
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2026Protein Production Facility
ResearchInvestigator · Awarded by Bill and Melinda Gates Foundation · 2022 - 2026NIAID Virology Quality Assurance - Year 6 Option 5
ResearchQuality Management Coordinator · Awarded by National Institutes of Health · 2019 - 2026Immunogenicity (Serum IgG)
ResearchInvestigator · Awarded by Uvax Bio, LLC · 2024 - 2026Neutralizing Antibody Assessment for UVAX-HIV-101 Human Clinical Trial Study
ResearchDirector · Awarded by Uvax Bio, LLC · 2024 - 2026Surgical Critical Care Initiative (SC2I): Civilian application of military decision support tools for critically injured patients.
ResearchAuditor · Awarded by Henry M. Jackson Foundation · 2021 - 2026HVTN Laboratory Center: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2025Antibody Dynamics for BNT165b1
ResearchResearch Associate · Awarded by BioNTech SE · 2023 - 2025CIVICS Component A - Option 5
ResearchQA Liaison · Awarded by National Institutes of Health · 2019 - 2025CIVICS A - Option 21A Equitable Adjustment
ResearchDirector · Awarded by National Institutes of Health · 2022 - 2025CIVICS A - Option 21A
ResearchDirector · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2025Neutralizing Antibody Assessment for SARS-CoV-2 Vaccine Trials
ResearchDirector · Awarded by Vaccine Company, Inc. · 2023 - 2025Nonhuman Primate Option 6
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2025Moderma COVID/Flu 1083-P301
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2024 - 2025Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses - Option 5
ResearchQA Liaison · Awarded by National Institutes of Health · 2023 - 2024HVTN 706
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2023 - 2024CoVPN 5001 A Prospective Study of Acute Immune Responses to SARS-CoV-2 Infection
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2024CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2024CISA Maternal COVID Immunogenicity
ResearchDirector, QA/QC · Awarded by Centers for Disease Control and Prevention · 2022 - 2024CISA COVID Flu Immunogenicity
ResearchDirector, QA/QC · Awarded by Centers for Disease Control and Prevention · 2022 - 2024CISA COVID Peds Immunogenicity
ResearchDirector, QA/QC · Awarded by Centers for Disease Control and Prevention · 2022 - 2024EQAPOL - Years 2017 to 2024 - BASE
ResearchDirector, QA/QC · Awarded by National Institutes of Health · 2017 - 2024EQAPOL OPTION 6 (YEAR 7)
ResearchQuality Management Coordinator · Awarded by National Institutes of Health · 2017 - 2024A Phase 1, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18-55 Years
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2024Moderna mRNA1275 P205 Trial Neutralizing Antibody Assessment
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2024A phase 2 randomized, open-label, parallel group study to assess the immunogenicity, safety, and tolerability of Moderna mRNA-1273 vaccine administered with casirivimab+imdevimab in healthy adult volunteers
ResearchInvestigator · Awarded by Regeneron Pharmaceuticals, Inc. · 2021 - 2024HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2023CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2022 - 2023HVTN Laboratory Center: 702 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2020 - 2023A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Observer-Blind, Placebo-Controlled, Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effe
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2023Moderna mRNA-1273 P201 (Part B) Trial Neutralizing Antibody Assessment
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2023A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS-CoV-2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2023Neutralizing Antibody Response Assessment for a Phase 2/3 Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccin
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2023HVTN 705 Case Control Janssen
ResearchInvestigator · Awarded by Fred Hutchinson Cancer Center · 2021 - 2022CoVPN 3005: Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older
ResearchCo Investigator · Awarded by Seattle Cancer Care Alliance · 2022 - 2022CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
ResearchCo Investigator · Awarded by Seattle Cancer Care Alliance · 2022 - 2022Protein Production Facility
ResearchDirector, QA/QC · Awarded by Bill and Melinda Gates Foundation · 2016 - 2022A PHASE 2a, RANDOMIZED, OBSERVER-BLIND, PLACEBO-CONTROLLED, DOSE-CONFIRMATION STUDY TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF MRNA-1273 SARS-COV-2 VACCINE IN ADULTS AGED 18 YEARS A
ResearchDirector · Awarded by Moderna Therapeutics, Inc. · 2021 - 2022Neutralizing antibody assessment for EID 030 SARS-CoV-2 Vaccine Phase I trial
ResearchDirector · Awarded by Henry M. Jackson Foundation · 2021 - 2022HVTN Laboratory Center: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022CoVPN 5001 A prospective study of acute immune responses to SARS-CoV2 infection - LAB
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2022HVTN 705 Pilot
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2021HVTN Laboratory Center: P5 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2020 - 2021Immunologic control of HIV-1 through combination bNAbs and biologics
ResearchDirector, QA/QC · Awarded by Rockefeller University · 2020 - 2021Sc2i
ResearchAuditor · Awarded by Henry M. Jackson Foundation · 2020 - 2021HVTN Laboratory Center: HVTN Phase 1
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2020HVTN Laboratory Center: HVTN 118
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2006 - 2020SC2i
ResearchQA Liaison · Awarded by Henry M. Jackson Foundation · 2014 - 2020HVTN TB Correlates Pilot Studies Supplement
ResearchQA Liaison · Awarded by Fred Hutchinson Cancer Research Center · 2019 - 2019HVTN Laboratory Center: HVTN 118
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2017 - 2018HVTN Laboratory Center: HVTN 117
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2017 - 2018HVTN - A004
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2018HIV Vaccine Trials Network: LC P5 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2015 - 2018Nonhuman Primate Core-Option 6
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2018EQAPOL Option 47
ResearchInvestigator · Awarded by National Institutes of Health · 2011 - 2017EQAPOL - Option 48 - 2016 to 2017 - LUMINEX
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2017EQAPOL - 2016 to 2017 - Option 6 - BASE
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2017EQAPOL Option 5
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2017Animal Models of Infectious Diseases Part A
ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2017LC: HIV Vaccine Trials Network: Phase 1 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2014 - 2015HIV Vaccine Trials Network: LC P5 PF
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2014 - 2015IQA Option 4
ResearchSafety Coordinator · Awarded by National Institutes of Health · 2007 - 2014Production of HIV-1 Envs #2
ResearchInvestigator · Awarded by Foundation for the National Institutes of Health · 2012 - 2013Mechanisms of Allogeneic Stem Cell Education in SCID
ResearchInvestigator · Awarded by National Institutes of Health · 1999 - 2012Role Of Surfactant In Innate and Adaptive Immunity
ResearchConsultant · Awarded by National Institutes of Health · 2001 - 2011Dose Study of Thymus Transplantation, IND 9836
ResearchConsultant · Awarded by Food and Drug Administration · 2005 - 2008Thymic Transplantation in Complete DiGeorge Syndrome
ResearchInvestigator · Awarded by National Institutes of Health · 1999 - 2004Memory T Cell Induction In Neonates By Viral Vaccines
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 2002External Relationships
- QualCon, Inc., a consulting company
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.